What does CUSIP 87164F105 represent in this 13F holders report?

CUSIP 87164F105 is the security identifier for SNDX - Syndax Pharmaceuticals Inc - Common Stock used to aggregate holder disclosures.

How many institutions held SNDX - Syndax Pharmaceuticals Inc - Common Stock in Q2 2018?

83 institutional investors reported SNDX - Syndax Pharmaceuticals Inc - Common Stock for Q2 2018. Use the holders table for investor-level position and value details.

Syndax Pharmaceuticals Inc - Common Stock (SNDX)

CUSIP: 87164F105

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Equity / Common Stock
Shares outstanding: 88,260,257
Total 13F shares: 15,085,582
Share change: -2,086,760
Total reported value: $105,898,739
Put/Call ratio: 114%
Price per share: $7.02
Number of holders: 83
Value change: -$23,251,843
Number of buys: 48
Number of sells: 28

Quarterly Holders Quick Answers

What is CUSIP 87164F105?
CUSIP 87164F105 identifies SNDX - Syndax Pharmaceuticals Inc - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2018
Previous quarter: Q1 2018

Recent filing periods for CUSIP 87164F105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SNDX - Syndax Pharmaceuticals Inc - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	3.9%	3,457,712	$49,203,000	—	31 Mar 2018	13F
BVF INC/IL	13F	Company	3.7%	3,233,618	$46,014,000	—	31 Mar 2018	13F
MPM ASSET MANAGEMENT LLC	13F	Company	2.5%	2,168,691	$30,860,000	—	31 Mar 2018	13F
BlackRock Finance, Inc.	13F	Company	1.4%	1,276,671	$18,168,000	—	31 Mar 2018	13F
VANGUARD GROUP INC	13F	Company	0.84%	743,944	$10,586,000	—	31 Mar 2018	13F
FMR LLC	13F	Company	0.63%	560,202	$7,972,000	—	31 Mar 2018	13F
ORBIMED ADVISORS LLC	13F	Company	0.5%	437,000	$6,219,000	—	31 Mar 2018	13F
JPMORGAN CHASE & CO	13F	Company	0.48%	426,941	$6,075,000	—	31 Mar 2018	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.45%	397,579	$5,658,000	—	31 Mar 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.39%	341,313	$4,857,000	—	31 Mar 2018	13F
Alyeska Investment Group, L.P.	13F	Company	0.37%	327,955	$4,667,000	—	31 Mar 2018	13F
Point72 Asset Management, L.P.	13F	Company	0.34%	300,000	$4,269,000	—	31 Mar 2018	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.34%	298,472	$4,247,000	—	31 Mar 2018	13F
683 Capital Management, LLC	13F	Company	0.32%	283,230	$4,030,000	—	31 Mar 2018	13F
MORGAN STANLEY	13F	Company	0.27%	240,266	$3,419,000	—	31 Mar 2018	13F
Opaleye Management Inc.	13F	Company	0.25%	222,500	$3,166,000	—	31 Mar 2018	13F
Tekla Capital Management LLC	13F	Company	0.23%	200,000	$2,846,000	—	31 Mar 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.18%	154,556	$2,199,000	—	31 Mar 2018	13F
Artal Group S.A.	13F	Company	0.17%	150,000	$2,135,000	—	31 Mar 2018	13F
NORTHERN TRUST CORP	13F	Company	0.16%	143,731	$2,046,000	—	31 Mar 2018	13F
Asymmetry Capital Management, L.P.	13F	Company	0.15%	135,974	$1,935,000	—	31 Mar 2018	13F
TIVERTON ASSET MANAGEMENT LLC	13F	Company	0.15%	132,318	$1,883,000	—	31 Mar 2018	13F
STATE STREET CORP	13F	Company	0.15%	129,941	$1,851,000	—	31 Mar 2018	13F
UNITED SERVICES AUTOMOBILE ASSOCIATION	13F	Company	0.15%	128,198	$1,824,000	—	31 Mar 2018	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.14%	122,567	$1,744,000	—	31 Mar 2018	13F
PDT Partners, LLC	13F	Company	0.13%	110,866	$1,578,000	—	31 Mar 2018	13F
Boxer Capital, LLC	13F	Company	0.11%	100,000	$1,423,000	—	31 Mar 2018	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.11%	98,039	$1,395,000	—	31 Mar 2018	13F
PRELUDE CAPITAL MANAGEMENT, LLC	13F	Company	0.08%	71,938	$1,024,000	—	31 Mar 2018	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.06%	56,258	$801,000	—	31 Mar 2018	13F
Meadow Creek Investment Management LLC	13F	Company	0.06%	54,978	$782,000	—	31 Mar 2018	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.06%	52,500	$747,000	—	31 Mar 2018	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.06%	50,500	$719,000	—	31 Mar 2018	13F
Bank of New York Mellon Corp	13F	Company	0.05%	46,480	$661,000	—	31 Mar 2018	13F
Elkfork Partners LLC	13F	Company	0.05%	45,276	$644,000	—	31 Mar 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.05%	44,496	$632,000	—	31 Mar 2018	13F
J. Goldman & Co LP	13F	Company	0.04%	39,538	$563,000	—	31 Mar 2018	13F
Crestline Management, LP	13F	Company	0.04%	36,714	$522,000	—	31 Mar 2018	13F
Glen Harbor Capital Management LLC	13F	Company	0.04%	35,574	$506,000	—	31 Mar 2018	13F
ALPS ADVISORS INC	13F	Company	0.04%	32,712	$465,000	—	31 Mar 2018	13F
Neuburgh Advisers LLC	13F	Company	0.03%	25,872	$368,000	—	31 Mar 2018	13F
TEACHERS ADVISORS, LLC	13F	Company	0.03%	25,568	$364,000	—	31 Mar 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.03%	24,400	$348,000	—	31 Mar 2018	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.02%	18,197	$259,000	—	31 Mar 2018	13F
OPPENHEIMER & CO INC	13F	Company	0.02%	16,651	$237,000	—	31 Mar 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.02%	16,409	$234,000	—	31 Mar 2018	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.02%	14,813	$211,000	—	31 Mar 2018	13F
Paloma Partners Management Co	13F	Company	0.02%	13,800	$196,000	—	31 Mar 2018	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.01%	13,152	$187,000	—	31 Mar 2018	13F
ProShare Advisors LLC	13F	Company	0.01%	12,782	$182,000	—	31 Mar 2018	13F

Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock (SNDX) as of Q2 2018

As of 30 Jun 2018, Syndax Pharmaceuticals Inc - Common Stock (SNDX) was held by 83 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,085,582 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, MPM ASSET MANAGEMENT LLC, BlackRock Inc., BVF INC/IL, VANGUARD GROUP INC, FMR LLC, DIMENSIONAL FUND ADVISORS LP, ORBIMED ADVISORS LLC, 683 Capital Management, LLC, and Alyeska Investment Group, L.P.. This page lists 83 institutional shareholders reporting positions in this security for the Q2 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

Q2 2018 holders

Holder diff

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 Value $	Q2 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.